What is Glaia?
Founded in 2019 and headquartered in Bristol, United Kingdom, Glaia operates at the intersection of biotechnology and sustainable farming. The company specializes in developing proprietary technology designed to enhance the efficiency of photosynthesis in crops. By improving the fundamental biological processes that drive plant growth, Glaia aims to increase agricultural productivity without the need for additional land or excessive chemical inputs. This approach positions the company as a critical player in the climate-resilient agriculture market, providing scalable solutions for modern farming challenges.
How much funding has Glaia raised?
Glaia has raised a total of $1.3M across 1 funding round:
Angel/Seed
$1.3M
Angel/Seed (2022): $1.3M with participation from Green Angel Syndicate
Key Investors in Glaia
Green Angel Syndicate
Green Angel Syndicate is the UK's leading angel syndicate focused on combating climate change through sustainable investment solutions. They specialize in selecting and investing in innovative companies that address climate challenges, offering both active and passive investment opportunities.
What's next for Glaia?
With this major enterprise-level funding, Glaia is well-positioned to transition from its initial research and development phase into broader commercial deployment. The strategic roadmap likely involves scaling its photosynthesis-enhancing technology across diverse crop varieties and expanding its operational footprint within the international ag-tech landscape. As the company matures, the focus will shift toward rigorous field testing and establishing commercial partnerships with large-scale agricultural producers, ensuring that their scientific breakthroughs translate into tangible, high-impact results for the global food supply chain.
See full Glaia company page
